At the news
? BEARISHIMPACT 4/10 SC 13G/A filed Nov 10, 2026 at 15:20 ET
Invesco Ltd. filed an amended Schedule 13G disclosing a 3.9% passive stake in Collegium Pharmaceutical as of September 30, 2026, down from a prior 5%+ position. The filing indicates Invesco reduced its holdings below the 5% threshold, continuing a pattern of institutional exits from Collegium.
- Invesco Ltd. filed an amended Schedule 13G disclosing beneficial ownership of 1,261,037 shares of Collegium Pharmaceutical common stock as of September 30, 2026.
- The stake represents 3.9% of shares outstanding, down from a prior 5%+ position.
- This is the third institutional filer in recent weeks to report a stake below 5% (following Vanguard and Principal Global Investors).
- The filing was made under Rule 13d-1(b), confirming passive intent.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access